Search results for "Antidepressant drug therapy"

showing 4 items of 4 documents

Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity.

2017

Response to antidepressant treatment in major depressive disorder (MDD) cannot be predicted currently, leading to uncertainty in medication selection, increasing costs, and prolonged suffering for many patients. Despite tremendous efforts in identifying response-associated genes in large genome-wide association studies, the results have been fairly modest, underlining the need to establish conceptually novel strategies. For the identification of transcriptome signatures that can distinguish between treatment responders and nonresponders, we herein submit a novel animal experimental approach focusing on extreme phenotypes. We utilized the large variance in response to antidepressant treatmen…

0301 basic medicineMicroarraysPhysiologyGene ExpressionBioinformaticsBiochemistryBiomarkers PharmacologicalTranscriptomeMice0302 clinical medicineGlucocorticoid receptorMedicine and Health SciencesBiology (General)DepressionGeneral NeuroscienceBrainDrugsAntidepressantsPhenotypeAntidepressive Agents3. Good healthBody FluidsParoxetineBioassays and Physiological AnalysisBloodMice Inbred DBAMultigene FamilyMajor depressive disorderAntidepressantDNA microarrayAnatomyGeneral Agricultural and Biological SciencesResearch ArticleQH301-705.5Antidepressant drug therapy ; Blood ; Gene regulation ; Biomarkers ; Depression ; Gene expression ; Microarrays ; AntidepressantsBiologyResearch and Analysis MethodsGeneral Biochemistry Genetics and Molecular BiologyBlood Plasma03 medical and health sciencesReceptors GlucocorticoidMental Health and PsychiatrymedicineGeneticsAnimalsHumansGene RegulationPharmacologyDepressive Disorder MajorGeneral Immunology and MicrobiologyMechanism (biology)Mood DisordersGene Expression ProfilingBiology and Life Sciencesmedicine.diseaseGene expression profiling030104 developmental biologyGene Expression RegulationCorticosterone030217 neurology & neurosurgeryBiomarkersPLoS biology
researchProduct

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review wi…

2017

Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used for the management of ADHD. We aimed to compare the efficacy and safety of pharmacological, psychological and complementary and alternative medicine interventions for the treatment of ADHD in children and adolescents. Methods and findings We performed a systematic review with network meta-analyses. Randomised controlled trials (≥ 3 weeks follow-up) were identified from published and unpublished sources through searches in PubMed and the Cochrane Library (up to April 7, 2016). Interventions of interest were pharmacolo…

Complementary TherapiesMaleTrastorns de l'atencióPoison controllcsh:MedicineMathematical and Statistical Techniques0302 clinical medicineBehavior TherapyMedicine and Health SciencesMedicine030212 general & internal medicineChildlcsh:ScienceRandomized Controlled Trials as TopicMultidisciplinaryPharmaceuticsMethylphenidate3. Good healthGuanfacineAntidepressant Drug TherapyNeurologyTolerabilityBehavioral PharmacologyResearch DesignPhysical SciencesFemaleStatistics (Mathematics)Research Articlemedicine.drugNeurological Drug Therapymedicine.medical_specialtyAdolescentClinical Research DesignNeuropsychiatric DisordersResearch and Analysis MethodsPlacebo03 medical and health sciencesDevelopmental NeuroscienceDrug TherapyInternal medicineMental Health and PsychiatryHumansAttention deficit hyperactivity disorderPsiquiatriaStatistical MethodsAdverse effectPsychiatryPharmacologyBehaviorbusiness.industryAtomoxetinelcsh:RCentral Nervous System DepressantsBiology and Life Sciencesmedicine.diseaseAttention Deficit Disorder with HyperactivityNeurodevelopmental DisordersCentral Nervous System StimulantsAdhdlcsh:QAdverse EventsbusinessMental Health TherapiesMathematics030217 neurology & neurosurgeryNeuroscienceMeta-AnalysisPLoS ONE
researchProduct

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.

2021

Introduction The aim of this study was to describe the number and type of drugs used to treat depressive disorders in inpatient psychiatry and to analyse the determinants of potential drug-drug interactions (pDDI) and potentially inappropriate medication (PIM). Methods Our study was part of a larger pharmacovigilance project funded by the German Innovation Funds. It included all inpatients with a main diagnosis in the group of depressive episodes (F32, ICD-10) or recurrent depressive disorders (F33) discharged from eight psychiatric hospitals in Germany between 1 October 2017 and 30 September 2018 or between 1 January and 31 December 2019. Results The study included 14,418 inpatient cases.…

Epidemiologymedicine.medical_treatment0302 clinical medicineRisk FactorsMedicine and Health SciencesAntipsychoticsDrug Interactions030212 general & internal medicineDepression (differential diagnoses)Potentially Inappropriate Medication Listmedia_commonMultidisciplinaryDepressionPharmaceuticsQRDrugsAntidepressantsMiddle AgedAntidepressive AgentsAntidepressant Drug TherapyMedicineAntidepressantDrug Therapy CombinationAntipsychotic AgentsResearch ArticleDrugNeurological Drug Therapymedicine.medical_specialtyPatientsSciencemedia_common.quotation_subject03 medical and health sciencesPharmacotherapyDrug TherapyInternal medicinePharmacovigilanceMental Health and PsychiatrymedicineHumansAntipsychoticProbabilityPolypharmacyPharmacologyInpatientsbusiness.industryMood DisordersOdds ratioHealth CareLogistic ModelsMedical Risk Factorsbusiness030217 neurology & neurosurgeryReceptor Antagonist TherapyPloS one
researchProduct

Reduction of depressive symptoms during inpatient treatment is not associated with changes in heart rate variability

2021

Vagally mediated heart rate variability (HRV) is a psychophysiological indicator of mental and physical health. Limited research suggests there is reduced vagal activity and resulting lower HRV in patients with Major Depressive Disorder (MDD); however little is actually known about the association between HRV and symptoms of depression and whether the association mirrors symptom improvement following psychotherapy. The aim of this study was to investigate the association between antidepressant therapy, symptom change and HRV in 50 inpatients (68% females; 17–68 years) with a diagnosis of MDD. Severity of depressive symptoms was assessed by self-report (Beck Depression Inventory II) and the …

MalePsychometricsSocial SciencesCardiovascular MedicineMedical ConditionsHeart RateMedicine and Health SciencesPsychologyMedicineHeart rate variabilityDepression (differential diagnoses)MultidisciplinaryDepressionPharmaceuticsQRDrugsAntidepressantsMiddle AgedAntidepressant Drug TherapyCardiovascular DiseasesMedicineMajor depressive disorderFemaleResearch Articlecirculatory and respiratory physiologyClinical psychologyNeurological Drug TherapyAdultPatientsPsychometricsAdolescentScienceCardiologyYoung AdultDrug Therapy:Medisinske Fag: 700 [VDP]Rating scaleMental Health and PsychiatryHumansIn patientDepressive symptomsAgedPharmacologyInpatientsDepressive Disorder MajorMood Disordersbusiness.industryBeck Depression InventoryBiology and Life Sciencesmedicine.diseaseHealth CarePsychotherapybusinessMental Health Therapies
researchProduct